Citations (121)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Kat Kolar, Tara Elton-Marshall, Robert E. Mann & Hayley A. Hamilton. (2020) Routes of cannabis administration among adolescents during criminal prohibition of cannabis in Canada. Drugs: Education, Prevention and Policy 27:5, pages 421-426.
Read now
Read now
Gemma T. Wallace, Bradley T. Conner & Audrey M. Shillington. (2019) Using Classification Trees to Examine Predictors of Marijuana Use Among a Wide Range of Variables. Substance Use & Misuse 54:11, pages 1799-1811.
Read now
Read now
Veronica E. Graham & Alan R. Clough. (2019) “Need Everyone Helping to Keep Off Because Everyone Helping to Keep On” – Reducing Harms from Cannabis use in Remote Indigenous Australian Communities Involves More Than Just Users. Substance Use & Misuse 54:5, pages 699-712.
Read now
Read now
Ian Hamilton, Mark Monaghan & Charlie Lloyd. (2019) Rising numbers of older and female cannabis users seeking treatment in England and Wales. Drugs: Education, Prevention and Policy 26:2, pages 205-207.
Read now
Read now
Jeff Randall, Phillippe B. Cunningham & Scott W. Henggeler. (2018) The Development and Transportability of Multisystemic Therapy-Substance Abuse: A Treatment for Adolescents with Substance Use Disorders. Journal of Child & Adolescent Substance Abuse 27:2, pages 59-66.
Read now
Read now
Hans B. Dupont, Math J. J. M. Candel, Paul Lemmens, Charles D. Kaplan, Dike van de Mheen & Nanne K. De Vries. (2017) Stages of Change Model has Limited Value in Explaining the Change in Use of Cannabis among Adolescent Participants in an Efficacious Motivational Interviewing Intervention. Journal of Psychoactive Drugs 49:5, pages 363-372.
Read now
Read now
Jan Copeland & Izabella Pokorski. (2016) Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. Substance Abuse and Rehabilitation 7, pages 41-53.
Read now
Read now
Bernadette Rogerson & Susan P. Jacups. (2016) “Stressing out”: defining severity of cannabis withdrawal symptoms in Australian indigenous inmates. Journal of Substance Use 21:4, pages 368-373.
Read now
Read now
Corey J. Keller, Evan C. Chen, Kimberly Brodsky & Jong H. Yoon. (2016) A case of butane hash oil (marijuana wax)–induced psychosis. Substance Abuse 37:3, pages 384-386.
Read now
Read now
Bernadette Rogerson, Susan P. Jacups & Nerina Caltabiano. (2016) Cannabis use, dependence and withdrawal in indigenous male inmates. Journal of Substance Use 21:1, pages 65-71.
Read now
Read now
Mark Monaghan, Ian Hamilton, Charlie Lloyd & Kirsteen Paton. (2016) Cannabis matters? Treatment responses to increasing cannabis presentations in addiction services in England. Drugs: Education, Prevention and Policy 23:1, pages 54-61.
Read now
Read now
Maayan Nagar & Sharon Rabinovitz. (2015) Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption. Journal of Psychoactive Drugs 47:2, pages 91-99.
Read now
Read now
Ann Roche, Victoria Adams & Michael White. (2014) Up in smoke: Cannabis content in alcohol and other drug qualifications. Drugs: Education, Prevention and Policy 21:2, pages 140-146.
Read now
Read now
Kirsten C Morley, Paul S Haber, Madeleine L Morgan & Fares Samara. (2012) Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Substance Abuse and Rehabilitation 3, pages 43-47.
Read now
Read now
Jonathan N. Stea & David C. Hodgins. (2012) The relationship between lack of control and illusory pattern perception among at-risk gamblers and at-risk cannabis users. The Social Science Journal 49:4, pages 528-536.
Read now
Read now
Articles from other publishers (106)
Muhammad Tahir Khalily, Basharat Hussain, Brian Hallahan, Shahid Irfan, Neelam Ehsan, Muhammad Saghir, Syeda Ayat-e-Zainab Ali, Shamsher Hayat Khan, Tanveer Akhtar & Muhammad Abbas. (2023) Indigenously Adapted Community Reinforcement Approach (IA-CRA) for Cannabis Users: a Randomized Controlled Trial. International Journal of Mental Health and Addiction.
Crossref
Crossref
Vishal Hegde, Daniel N. Bracey, Aviva K. Pollet, Yasmin Yazdani-Farsad, Douglas A. Dennis & Jason M. Jennings. (2023) Cannabis Use Does Not Affect Outcomes After Total Hip Arthroplasty. The Journal of Arthroplasty 38:9, pages 1808-1811.
Crossref
Crossref
Qian Wang & Hui Wang. (2023) Cannabis and tobacco use among adolescents aged 12-17 years from 16 low- and middle-income countries. Journal of Global Health 13.
Crossref
Crossref
Anthony K. Chiu, Samuel I. Fuller, Amil R. Agarwal, Kendrick J. Cuero, Rachel A. Ranson, R. Timothy Kreulen, Matthew J. Best & Umasuthan Srikumaran. (2023) Cannabis use disorder is not a risk factor for thrombotic events or medical complications following total shoulder arthroplasty. Seminars in Arthroplasty: JSES 33:2, pages 379-384.
Crossref
Crossref
Ruibin Lu. (2023) Marijuana Policies in Drug Treatment Courts. Journal of Drug Issues, pages 002204262311637.
Crossref
Crossref
Pravesh Sharma, Doug B Mathews, Quang Anh Nguyen, Gillian L Rossmann, Christi A Patten & Christopher J Hammond. (2023) Old Dog, New Tricks: A Review of Identifying and Addressing Youth Cannabis Vaping in the Pediatric Clinical Setting. Clinical Medicine Insights: Pediatrics 17, pages 117955652311622.
Crossref
Crossref
Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor & Nicholas Lintzeris. (2022) Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Christina Schell, Alexandra Godinho & John A. Cunningham. (2022) Examining the influence of rurality on frequency of cannabis use and severity of consequences as moderated by age and gender. Addictive Behaviors 133, pages 107385.
Crossref
Crossref
Christina Moska, Anna E. Goudriaan, Peter Blanken, Dike van de Mheen, Renske Spijkerman, Arnt Schellekens, Jannet de Jonge, Floris Bary, Wilma Vollebergh & Vincent Hendriks. (2021) Youth in transition: Study protocol of a prospective cohort study into the long-term course of addiction, mental health problems and social functioning in youth entering addiction treatment. BMC Psychiatry 21:1.
Crossref
Crossref
Mehdi Akbari, Mohammad Hossein Bahadori, Shahram Mohammadkhani, Daniel C. Kolubinski, Ana V. Nikčević & Marcantonio M. Spada. (2021) A discriminant analysis model of psychosocial predictors of problematic Internet use and cannabis use disorder in university students. Addictive Behaviors Reports 14, pages 100354.
Crossref
Crossref
Anees Bahji, Arthi Chinna Meyyappan, Emily R Hawken & Philip G. Tibbo. (2021) Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. International Journal of Drug Policy 97, pages 103295.
Crossref
Crossref
Silvia S. Martins, Luis E. Segura, Natalie S. Levy, Pia M. Mauro, Christine M. Mauro, Morgan M. Philbin & Deborah S. Hasin. (2021) Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws. JAMA Network Open 4:9, pages e2127002.
Crossref
Crossref
Luca Flesia, Valentina Fietta, Carlo Foresta & Merylin Monaro. (2021) The Relationship between Drug Consumption and Dating App Use: Results from an Italian Survey. Social Sciences 10:8, pages 290.
Crossref
Crossref
Seán R Millar, Deirdre Mongan, Claire O’Dwyer, Jean Long, Bobby P Smyth, Ivan J Perry & Brian Galvin. (2021) Correlates of patterns of cannabis use, abuse and dependence: evidence from two national surveys in Ireland. European Journal of Public Health 31:2, pages 441-447.
Crossref
Crossref
Devan M. Gomez, Thomas J. Everett, Lindsey R. Hamilton, Ajit Ranganath, Joseph F. Cheer & Erik B. Oleson. (2021) Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212–2 and heroin in adult male rats. Neuropharmacology 182, pages 108374.
Crossref
Crossref
Julia Sasiadek, Darby J.E. Lowe, Sarah-Maude Rioux & Tony P. George. 2021. Psychotic Disorders. Psychotic Disorders
107
124
.
Garth E. Terry, Vanessa Raymont & Andrew G. Horti. 2021. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
319
426
.
Albert J. Arias, Christopher J. Hammond, Joseph A. Burleson, Yifrah Kaminer, Richard Feinn, John F. Curry & Michael L. Dennis. (2020) Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder. Journal of Substance Abuse Treatment 117, pages 108087.
Crossref
Crossref
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
James Vaissiere, Jackson G. Thorp, Jue-Sheng Ong, Alfredo Ortega-Alonso & Eske M. Derks. (2020) Exploring Phenotypic and Genetic Overlap Between Cannabis Use and Schizotypy. Twin Research and Human Genetics 23:4, pages 221-227.
Crossref
Crossref
Kaushal Shah, Viraj V Joshi, Nkechi C Arinze, Krishna Priya Bodicherla, Shristee Ghimire, Romil Singh & Venkatesh Sreeram. (2020) Association of Opioid Use With Cardiometabolic Disease Risk Factors: Evidence From the 2009-2018 National Health and Nutrition Examination Survey. Cureus.
Crossref
Crossref
William Cabanillas-Rojas. (2020) Prevalence and Gender-Specific Predictors for the Use of Marijuana in the General Population of the Metropolitan Area of Lima, Peru: an Analysis of Contextual and Individual Factors. International Journal of Mental Health and Addiction 18:2, pages 395-406.
Crossref
Crossref
Anthony H. Ecker, Brent Lang, Julianna Hogan, Michael A. Cucciare & Jan Lindsay. (2020) Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization. Journal of Substance Abuse Treatment 109, pages 46-49.
Crossref
Crossref
Cristina Serna & Isabel Martínez. (2019) Parental Involvement as a Protective Factor in School Adjustment among Retained and Promoted Secondary Students. Sustainability 11:24, pages 7080.
Crossref
Crossref
Benedikt Fischer, Monica Malta, Guilherme Messas & Marcelo Ribeiro. (2019) Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil. Brazilian Journal of Psychiatry 41:6, pages 550-555.
Crossref
Crossref
Lucy Albertella, Lisa Gibson, Sally Rooke, Melissa M. Norberg & Jan Copeland. (2019) A smartphone app intervention for adult cannabis users wanting to quit or reduce their use: a pilot evaluation. Journal of Cannabis Research 1:1.
Crossref
Crossref
Joel Mader, Jacqueline M. Smith, Arfan R. Afzal, Andrew C.H. Szeto & Ken C. Winters. (2019) Correlates of lifetime cannabis use and cannabis use severity in a Canadian university sample. Addictive Behaviors 98, pages 106015.
Crossref
Crossref
Kara Bagot, Elizabeth Hodgdon, Natasha Sidhu, Kevin Patrick, Mikaela Kelly, Yang Lu & Eraka Bath. (2019) End User–Informed Mobile Health Intervention Development for Adolescent Cannabis Use Disorder: Qualitative Study. JMIR mHealth and uHealth 7:10, pages e13691.
Crossref
Crossref
Kim G.C. Hellemans, Jessica Wilcox, Julian N. Nino, Matthew Young & Robyn J. McQuaid. (2019) Cannabis Use, Anxiety, and Perceptions of Risk among Canadian Undergraduates: The Moderating Role of Gender. Canadian Journal of Addiction 10:3, pages 22-29.
Crossref
Crossref
Margaret Haney, Ziva D. Cooper, Gillinder Bedi, Evan Herrmann, Sandra D. Comer, Stephanie Collins Reed, Richard W. Foltin & Frances R. Levin. (2018) Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology 24:4, pages 707-716.
Crossref
Crossref
Benedikt Fischer, Cayley Russell, Jürgen Rehm & Pamela Leece. (2019) Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an ‘index’ for monitoring and evaluation. Journal of Public Health 41:2, pages 412-421.
Crossref
Crossref
Christine M. Mauro, Paul Newswanger, Julian Santaella-Tenorio, Pia M. Mauro, Hannah Carliner & Silvia S. Martins. (2017) Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004–2013. Prevention Science 20:2, pages 205-214.
Crossref
Crossref
Thimo M. van der Pol, Vincent Hendriks, Henk Rigter, Moran D. Cohn, Theo A. H. Doreleijers, Lieke van Domburgh & Robert R. J. M. Vermeiren. (2018) Multidimensional family therapy in adolescents with a cannabis use disorder: long-term effects on delinquency in a randomized controlled trial. Child and Adolescent Psychiatry and Mental Health 12:1.
Crossref
Crossref
Y. Faiad, B. Khoury, S. Daouk, M. Maj, J. Keeley, O. Gureje & G. Reed. (2017) Frequency of use of the International Classification of Diseases ICD-10 diagnostic categories for mental and behavioural disorders across world regions. Epidemiology and Psychiatric Sciences 27:6, pages 568-576.
Crossref
Crossref
Lauren R. Pacek, Jan Copeland, Lisa Dierker, Chinazo O. Cunningham, Silvia S. Martins & Renee D. Goodwin. (2018) Among whom is cigarette smoking declining in the United States? The impact of cannabis use status, 2002–2015. Drug and Alcohol Dependence 191, pages 355-360.
Crossref
Crossref
Joanna Jacobus, Charles T. Taylor, Kevin M. Gray, Lindsay R. Meredith, Anna M. Porter, Irene Li, Norma Castro & Lindsay M. Squeglia. (2018) A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users. Drug and Alcohol Dependence 187, pages 195-204.
Crossref
Crossref
Thimo M. van der Pol, Craig E. Henderson, Vincent Hendriks, Michael P. Schaub & Henk Rigter. (2017) Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder. International Journal of Offender Therapy and Comparative Criminology 62:6, pages 1573-1588.
Crossref
Crossref
Benedikt FischerWim van den BrinkWayne HallBernard LeFollJürgen RehmRobin Room. (2017) Fischer et al. Respond. American Journal of Public Health 107:12, pages e26-e27.
Crossref
Crossref
Andrew Tuck, Hayley A. Hamilton, Branka Agic, Anca R. Ialomiteanu & Robert E. Mann. (2017) Past year cannabis use and problematic cannabis use among adults by ethnicity in Ontario. Drug and Alcohol Dependence 179, pages 93-99.
Crossref
Crossref
Amie C. Hayley, Con Stough & Luke A. Downey. (2017) DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. European Neuropsychopharmacology 27:8, pages 732-743.
Crossref
Crossref
Jan Copeland, Izabella Pokorski & Lisa Gibson. (2017) Overview of Current State-of-the-Art Treatments for Cannabis Use Disorders, and Future Directions. Current Addiction Reports 4:2, pages 82-89.
Crossref
Crossref
Kelly E. Courtney, Margie Hernandez Mejia & Joanna Jacobus. (2017) Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review. Current Addiction Reports 4:2, pages 43-52.
Crossref
Crossref
F. Kay-Lambkin, A. Healey, A. Baker, W. Swift, L. Thornton & A. Turner. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
e202
e210
.
P. Gates & J. Copeland. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
1093
1100
.
Hiba Alblooshi, Gary K. Hulse, Ahmed El Kashef, Hanan Al Hashmi, Mansour Shawky, Hamad Al Ghaferi, Habiba Al Safar & Guan K. Tay. (2016) The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study. Substance Abuse Treatment, Prevention, and Policy 11:1.
Crossref
Crossref
Olivier J. Barthelemy, Mark A. Richardson, Howard J. Cabral & Deborah A. Frank. (2016) Prenatal, perinatal, and adolescent exposure to marijuana: Relationships with aggressive behavior. Neurotoxicology and Teratology 58, pages 60-77.
Crossref
Crossref
Randi Melissa Schuster, Ailish Hanly, Jodi Gilman, Alan Budney, Ryan Vandrey & A. Eden Evins. (2016) A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users. Drug and Alcohol Dependence 167, pages 199-206.
Crossref
Crossref
Lexine A. Stapinski, Alan A. Montgomery & Ricardo Araya. (2016) Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents. Drug and Alcohol Dependence 166, pages 109-115.
Crossref
Crossref
Elias Dakwar & Edward V. Nunes. (2016) New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders. Current Psychiatry Reports 18:7.
Crossref
Crossref
Carolyn Coffey & George C. Patton. (2016) Cannabis Use in Adolescence and Young Adulthood. The Canadian Journal of Psychiatry 61:6, pages 318-327.
Crossref
Crossref
Hans B. Dupont, Math J.J.M. Candel, Charles D. Kaplan, Dike van de Mheen & Nanne K. de Vries. (2016) Assessing the Efficacy of MOTI-4 for Reducing the Use of Cannabis Among Youth in the Netherlands: A Randomized Controlled Trial. Journal of Substance Abuse Treatment 65, pages 6-12.
Crossref
Crossref
M. Goorden, E. van der Schee, V.M. Hendriks & L. Hakkaart-van Roijen. (2016) Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial. Drug and Alcohol Dependence 162, pages 154-161.
Crossref
Crossref
Maria Scherma, Christian Dessì, Anna Lisa Muntoni, Salvatore Lecca, Valentina Satta, Antonio Luchicchi, Marco Pistis, Leigh V Panlilio, Liana Fattore, Steven R Goldberg, Walter Fratta & Paola Fadda. (2015) Adolescent Δ9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology 41:5, pages 1416-1426.
Crossref
Crossref
Benedikt Fischer, Sameer Imtiaz, Katherine Rudzinski & Jürgen Rehm. (2016) Crude estimates of cannabis-attributable mortality and morbidity in Canada–implications for public health focused intervention priorities. Journal of Public Health 38:1, pages 183-188.
Crossref
Crossref
Jordan P. Davis, Douglas C. Smith, Jason W. Morphew, Xinrong Lei & Saijun Zhang. (2015) Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment. Journal of Drug Issues 46:1, pages 64-83.
Crossref
Crossref
Boris B. Quednow & Marcus Herdener. 2016. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions
227
250
.
Robert Ali, Linda Gowing & Jennifer Harland. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
649
659
.
Hans B. Dupont, Paul Lemmens, Gerald Adriana, Dike van de Mheen & Nanne K. de Vries. (2015) Developing the Moti-4 intervention, assessing its feasibility and pilot testing its effectiveness. BMC Public Health 15:1.
Crossref
Crossref
Emma L. Barrett, Nicola C. Newton, Maree Teesson, Tim Slade & Patricia J. Conrod. (2015)
Adapting the personality-targeted
Preventure
program to prevent substance use and associated harms among high-risk Australian adolescents
. Early Intervention in Psychiatry 9:4, pages 308-315.
Crossref
Crossref
Delyse M Hutchinson, Edmund Silins, Richard P Mattick, George C Patton, David M Fergusson, Reza Hayatbakhsh, John W Toumbourou, Craig A Olsson, Jake M Najman, Elizabeth Spry, Robert J Tait, Louisa Degenhardt, Wendy Swift, Peter Butterworth & L John Horwood. (2015) How can data harmonisation benefit mental health research? An example of The Cannabis Cohorts Research Consortium. Australian & New Zealand Journal of Psychiatry 49:4, pages 317-323.
Crossref
Crossref
Lauren R. Pacek, Pia M. Mauro & Silvia S. Martins. (2015) Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. Drug and Alcohol Dependence 149, pages 232-244.
Crossref
Crossref
Florence Vorspan, Wajdi Mehtelli, Gaël Dupuy, Vanessa Bloch & Jean-Pierre Lépine. (2015) Anxiety and Substance Use Disorders: Co-occurrence and Clinical Issues. Current Psychiatry Reports 17:2.
Crossref
Crossref
R. F. Farmer, D. B. Kosty, J. R. Seeley, S. C. Duncan, M. T. Lynskey, P. Rohde, D. N. Klein & P. M. Lewinsohn. (2014) Natural course of cannabis use disorders. Psychological Medicine 45:1, pages 63-72.
Crossref
Crossref
Jennifer Harland, Linda Gowing & Robert Ali. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
293
312
.
Laura Elise Vogl, Nicola Clare Newton, Katrina Elizabeth Champion & Maree Teesson. (2014) A universal harm-minimisation approach to preventing psychostimulant and cannabis use in adolescents: a cluster randomised controlled trial. Substance Abuse Treatment, Prevention, and Policy 9:1.
Crossref
Crossref
Nicholas Spence, Samantha Wells, Julie George & Kathryn Graham. (2014) An Examination of Marijuana Use Among a Vulnerable Population in Canada. Journal of Racial and Ethnic Health Disparities 1:4, pages 247-256.
Crossref
Crossref
Jennifer Johnston, Nicholas Lintzeris, David J. Allsop, Anastasia Suraev, Jessica Booth, Dean S. Carson, David Helliwell, Adam Winstock & Iain S. McGregor. (2014) Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology 231:24, pages 4623-4636.
Crossref
Crossref
C. Barrowclough, M. Marshall, L. Gregg, M. Fitzsimmons, B. Tomenson, J. Warburton & F. Lobban. (2014) A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine 44:13, pages 2749-2761.
Crossref
Crossref
Tim Karl & Jonathon C. Arnold. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse
315
329
.
. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse
293
390
.
Andrei Szoke, Anne-Marie Galliot, Jean-Romain Richard, Aziz Ferchiou, Grégoire Baudin, Marion Leboyer & Franck Schürhoff. (2014) Association between cannabis use and schizotypal dimensions – A meta-analysis of cross-sectional studies. Psychiatry Research 219:1, pages 58-66.
Crossref
Crossref
Jan Copeland, Nicole Clement & Wendy Swift. (2014) Cannabis use, harms and the management of cannabis use disorder. Neuropsychiatry 4:1, pages 55-63.
Crossref
Crossref
E. Hoch, G. Bühringer, A. Pixa, K. Dittmer, J. Henker, A. Seifert & H.U. Wittchen. (2014) CANDIS treatment program for cannabis use disorders: Findings from a randomized multi-site translational trial. Drug and Alcohol Dependence 134, pages 185-193.
Crossref
Crossref
Amy Baker Dennis & Tamara Pryor. 2014. Eating Disorders, Addictions and Substance Use Disorders. Eating Disorders, Addictions and Substance Use Disorders
227
266
.
Andrew G. Horti, Vanessa Raymont & Garth E. Terry. 2014. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
249
319
.
Robert J. Tait, Renske Spijkerman & Heleen Riper. (2013) Internet and computer based interventions for cannabis use: A meta-analysis. Drug and Alcohol Dependence 133:2, pages 295-304.
Crossref
Crossref
Ivana Obradovic, Olivier Le Nézet & Stanislas Spilka. (2013) Jeunes usagers de drogues et demande d'aide. Agora débats/jeunesses N° 64:2, pages 61-76.
Crossref
Crossref
Laurent Karila, Aymeric Petit, Rim Zarmdini, Sarah Coscas, William Lowenstein & Michel Reynaud. (2013) Consommation de tabac et trouble lié à l’usage de substances illicites : que devrions-nous faire ?. La Presse Médicale 42:5, pages 795-805.
Crossref
Crossref
C. E. Sartor, A. Agrawal, M. T. Lynskey, A. E. Duncan, J. D. Grant, E. C. Nelson, P. A. F. Madden, A. C. Heath & K. K. Bucholz. (2012) Cannabis or alcohol first? Differences by ethnicity and in risk for rapid progression to cannabis-related problems in women. Psychological Medicine 43:4, pages 813-823.
Crossref
Crossref
Robert Woolard, Janette Baird, Richard Longabaugh, Ted Nirenberg, Christina S. Lee, Michael J. Mello & Bruce Becker. (2013) Project Reduce: Reducing alcohol and marijuana misuse: Effects of a brief intervention in the emergency department. Addictive Behaviors 38:3, pages 1732-1739.
Crossref
Crossref
Jan Copeland & John Howard. 2013. Clinical Handbook of Adolescent Addiction. Clinical Handbook of Adolescent Addiction
202
212
.
Benedikt Fischer, Meghan Dawe, Fraser McGuire, Paul A. Shuper, Rielle Capler, Dan Bilsker, Wayne Jones, Benjamin Taylor, Katherine Rudzinski & Jürgen Rehm. (2013) Feasibility and impact of brief interventions for frequent cannabis users in Canada. Journal of Substance Abuse Treatment 44:1, pages 132-138.
Crossref
Crossref
Benedikt Fischer, Wayne Jones, Paul Shuper & Jürgen Rehm. (2012) 12-month follow-up of an exploratory ‘brief intervention’ for high-frequency cannabis users among Canadian university students. Substance Abuse Treatment, Prevention, and Policy 7:1.
Crossref
Crossref
Nicola C Newton, Maree Teesson, Emma L Barrett, Tim Slade & Patricia J Conrod. (2012) The CAP study, evaluation of integrated universal and selective prevention strategies for youth alcohol misuse: study protocol of a cluster randomized controlled trial. BMC Psychiatry 12:1.
Crossref
Crossref
Maree Teesson, Tim Slade, Wendy Swift, Katherine Mills, Sonja Memedovic, Louise Mewton, Rachel Grove, Nicola Newton & Wayne Hall. (2012) Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia. Australian & New Zealand Journal of Psychiatry 46:12, pages 1182-1192.
Crossref
Crossref
Peter J. Gates, Melissa M. Norberg, Jan Copeland & Erol Digiusto. (2012) Randomized controlled trial of a novel cannabis use intervention delivered by telephone. Addiction 107:12, pages 2149-2158.
Crossref
Crossref
Randi Melissa Schuster, Natania A. Crane, Robin Mermelstein & Raul Gonzalez. (2012) The Influence of Inhibitory Control and Episodic Memory on the Risky Sexual Behavior of Young Adult Cannabis Users. Journal of the International Neuropsychological Society 18:5, pages 827-833.
Crossref
Crossref
PETER GATES, JAN COPELAND, WENDY SWIFT & GREG MARTIN. (2011) Barriers and facilitators to cannabis treatment. Drug and Alcohol Review 31:3, pages 311-319.
Crossref
Crossref
Martin Cohen, Paul E. Rasser, Greg Peck, Vaughan J. Carr, Philip B. Ward, Paul M. Thompson, Patrick Johnston, Amanda Baker & Ulrich Schall. (2012) Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. International Journal of Neuropsychopharmacology 15:3, pages 297-307.
Crossref
Crossref
E. Hoch, R. Noack, J. Henker, A. Pixa, M. Höfler, S. Behrendt, G. Bühringer & H.-U. Wittchen. (2012) Efficacy of a targeted cognitive–behavioral treatment program for cannabis use disorders (CANDIS*). European Neuropsychopharmacology 22:4, pages 267-280.
Crossref
Crossref
Katherine Rudzinski, Fraser McGuire, Meghan Dawe, Paul Shuper, Dan Bilsker, Rielle Capler, Jürgen Rehm & Benedikt Fischer. (2012) Brief Intervention Experiences of Young High-Frequency Cannabis Users in a Canadian Setting. Contemporary Drug Problems 39:1, pages 49-72.
Crossref
Crossref
Laura E. Vogl, Maree Teesson, Nicola C. Newton & Gavin Andrews. (2012) Developing a school-based drug prevention program to overcome barriers to effective program implementation: The CLIMATE schools: Alcohol module. Open Journal of Preventive Medicine 02:03, pages 410-422.
Crossref
Crossref
Nadia Solowij, Katy A. Jones, Megan E. Rozman, Sasha M. Davis, Joseph Ciarrochi, Patrick C.L. Heaven, Nicole Pesa, Dan I. Lubman & Murat Yücel. (2011) Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology 219:2, pages 575-586.
Crossref
Crossref
David J. Allsop, Melissa M. Norberg, Jan Copeland, Shanlin Fu & Alan J. Budney. (2011) The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence 119:1-2, pages 123-129.
Crossref
Crossref
Nadia Solowij, Katy A. Jones, Megan E. Rozman, Sasha M. Davis, Joseph Ciarrochi, Patrick C. L. Heaven, Dan I. Lubman & Murat Yücel. (2011) Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology 216:1, pages 131-144.
Crossref
Crossref
Eva Hoch, Gerhard Bühringer, Jana Henker, Heike Rohrbacher, René Noack, Anja Pixa, Katrin Dittmer, Anne Rühlmann & Hans-Ulrich Wittchen. (2011) Untersuchungskonzept für die CANDIS 1CANnabis DISorders -Studie zur Behandlung von cannabisbezogenen Störungen: Ein Beispiel translationaler Forschung. SUCHT 57:3, pages 183-192.
Crossref
Crossref
R. Maldonado, F. Berrendero, A. Ozaita & P. Robledo. (2011) Neurochemical basis of cannabis addiction. Neuroscience 181, pages 1-17.
Crossref
Crossref
Claire E. Ramsay & Michael T. Compton. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume III. Handbook of Schizophrenia Spectrum Disorders, Volume III
289
320
.
Cheryl L. Beseler & Deborah S. Hasin. (2010) Cannabis dimensionality: Dependence, abuse and consumption. Addictive Behaviors 35:11, pages 961-969.
Crossref
Crossref
James J Burston, Jenny L Wiley, Abimbola A Craig, Dana E Selley & Laura J Sim-Selley. (2010) Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9-tetrahydrocannabinol exposure. British Journal of Pharmacology 161:1, pages 103-112.
Crossref
Crossref
Julia D. Buckner, Anthony H. Ecker & Alex S. Cohen. (2010) Mental health problems and interest in marijuana treatment among marijuana-using college students. Addictive Behaviors 35:9, pages 826-833.
Crossref
Crossref
NADIA SOLOWIJ. (2010) HARMS TO BODY AND SOUL ‐ AN IDEOLOGICAL BALANCING ACT FOR PREVENTING AND REDUCING CANNABIS USE. Addiction 105:8, pages 1331-1332.
Crossref
Crossref
Margaret Haney, Carl L. Hart, Suzanne K. Vosburg, Sandra D. Comer, Stephanie Collins Reed, Ziva D. Cooper & Richard W. Foltin. (2010) Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology 211:2, pages 233-244.
Crossref
Crossref
Heather Proudfoot, Laura Vogl, Wendy Swift, Greg Martin & Jan Copeland. (2010) Development of a short cannabis problems questionnaire for adolescents in the community. Addictive Behaviors 35:7, pages 734-737.
Crossref
Crossref
Nadia Solowij & Nicole Pesa. (2010) Anormalidades cognitivas no uso da cannabis. Revista Brasileira de Psiquiatria 32:suppl 1, pages 531-540.
Crossref
Crossref
Wendy Swift, Carolyn Coffey, John B. Carlin, Louisa Degenhardt, Bianca Calabria & George C. Patton. (2009) Are adolescents who moderate their cannabis use at lower risk of later regular and dependent cannabis use?. Addiction 104:5, pages 806-814.
Crossref
Crossref